Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial

[Image: see text]

Detalles Bibliográficos
Autores principales: Rosmarin, D., Smith, S., Shrom, D., Burge, R., See, K., McKean‐Matthews, M., Ridenour, T., Lin, C.‐Y., Gorelick, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060090/
https://www.ncbi.nlm.nih.gov/pubmed/35663140
http://dx.doi.org/10.1002/ski2.43
_version_ 1784698445311770624
author Rosmarin, D.
Smith, S.
Shrom, D.
Burge, R.
See, K.
McKean‐Matthews, M.
Ridenour, T.
Lin, C.‐Y.
Gorelick, J.
author_facet Rosmarin, D.
Smith, S.
Shrom, D.
Burge, R.
See, K.
McKean‐Matthews, M.
Ridenour, T.
Lin, C.‐Y.
Gorelick, J.
author_sort Rosmarin, D.
collection PubMed
description [Image: see text]
format Online
Article
Text
id pubmed-9060090
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90600902022-06-04 Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial Rosmarin, D. Smith, S. Shrom, D. Burge, R. See, K. McKean‐Matthews, M. Ridenour, T. Lin, C.‐Y. Gorelick, J. Skin Health Dis Letters to the Editor [Image: see text] John Wiley and Sons Inc. 2021-05-11 /pmc/articles/PMC9060090/ /pubmed/35663140 http://dx.doi.org/10.1002/ski2.43 Text en © 2021 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Rosmarin, D.
Smith, S.
Shrom, D.
Burge, R.
See, K.
McKean‐Matthews, M.
Ridenour, T.
Lin, C.‐Y.
Gorelick, J.
Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial
title Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial
title_full Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial
title_fullStr Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial
title_full_unstemmed Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial
title_short Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial
title_sort clinical outcomes at 1 year in early psoriasis area and severity index responders compared with non‐responders: subgroup analysis of uncover‐3 trial
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060090/
https://www.ncbi.nlm.nih.gov/pubmed/35663140
http://dx.doi.org/10.1002/ski2.43
work_keys_str_mv AT rosmarind clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial
AT smiths clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial
AT shromd clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial
AT burger clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial
AT seek clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial
AT mckeanmatthewsm clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial
AT ridenourt clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial
AT lincy clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial
AT gorelickj clinicaloutcomesat1yearinearlypsoriasisareaandseverityindexresponderscomparedwithnonresponderssubgroupanalysisofuncover3trial

Ejemplares similares